Ready to order?
Register / LoginIf you arrived here looking for BPC-157 dosage figures, this page will not give you any — and it is worth explaining why, because the reason is more useful than a number would be.
BPC-157 is a synthetic pentadecapeptide supplied as a laboratory research material. It is not approved by the FDA or any comparable regulator for any indication, in any population, at any quantity. That is not a technicality. It means there is no established dose, because establishing one is precisely what the approval process does and that process has never been completed for this compound. Any figure presented as a BPC-157 dose is therefore either a parameter from a specific animal study, quoted out of its context, or someone’s guess.
Why a Supplier Is the Wrong Source for Dosing Information
Even setting the regulatory position aside, a materials supplier is structurally the wrong place to look for parameters. There are three reasons.
The supplier does not know your model
Parameters in laboratory work follow from the study, not from the compound. A study in a rodent wound-healing model and a study in a cell culture system examining receptor activity have almost nothing in common in how the material is handled, quantified or introduced. A supplier who publishes one set of figures for all readers is publishing something that is wrong for nearly all of them.
Published figures vary enormously and are rarely comparable
The BPC-157 literature is heterogeneous. Studies differ in species, model, endpoint, formulation, duration and how quantities are normalised — which means figures taken from two papers frequently cannot be compared with each other, let alone transplanted into a third setting. Reducing that body of work to a range on a product page destroys the context that made each figure meaningful.
It is not the supplier’s decision to make
In a properly run laboratory, study parameters are set by the investigator and reviewed institutionally — through an animal care and use committee, an ethics board, or an equivalent body depending on jurisdiction and model. That review exists specifically so that these decisions are made by people who can see the whole study design. A vendor page cannot substitute for it, and a vendor that positions itself as the source of that information is doing something other than supplying materials.
Where Parameters Actually Come From in Laboratory Research
For researchers designing work with BPC-157, the sequence generally runs like this:
- Primary literature — identify studies using a model comparable to yours, and read the methods sections in full rather than the abstracts
- Institutional review — submit the proposed design to your IACUC, ethics committee or equivalent
- Pilot work — establish parameters empirically within your own system rather than importing them
- Documentation — record what was used and why, so results remain interpretable and reproducible
Nothing in that sequence involves a supplier website, and that is by design.
Reading the BPC-157 Literature
Most published BPC-157 work is preclinical, concentrated in rodent models, and produced by a relatively small number of research groups. When reading it, several things are worth holding in mind.
Study heterogeneity is high. Model systems, endpoints and measurement approaches differ substantially between papers, which limits how far findings can be generalised across them.
Independent replication is limited. A finding reported once is a finding reported once, and a substantial portion of the literature has not been reproduced by an unrelated group.
Human data is scarce. The controlled clinical evidence base for BPC-157 is very thin, which is a large part of why the compound has no approved status anywhere.
None of this makes the research uninteresting. It does mean the literature should be read as an open field rather than a settled one, and it is a further reason why a supplier reducing it to a number would be misleading.
What Meta Molecule Does Publish
What a supplier can meaningfully document is the material itself — and that is where our documentation is focused.
| We publish | Detail |
| Purity | Third-party HPLC verification, 99% standard |
| Molecular identity | Mass spectrometry confirmation against the expected sequence |
| Batch documentation | Batch-specific Certificate of Analysis for every production batch |
| Public access | COAs available at metamolecule.com/coas/ without login |
| Product specification | Stated fill weight and physical presentation per vial |
| Storage guidance | Cold storage conditions for lyophilised material |
| Regulatory status | Stated plainly: not approved, not for human or veterinary use |
That is the information a laboratory actually needs from a materials supplier: what is in the vial, how pure it is, who verified it, and how to store it. Everything downstream of that belongs to the study.
Regulatory Status
BPC-157 is not an approved drug. It is not available as a prescription medicine, it has not been evaluated by the FDA for safety or efficacy in humans, and it is not authorised for human or veterinary use in any jurisdiction we are aware of. Material supplied by Meta Molecule is sold for laboratory research use only, and access to the catalogue is restricted to qualified researchers on that basis.
Frequently Asked Questions
Q: What is the correct BPC-157 dosage?
A: There is no correct dosage, because BPC-157 has no approved use in any population. Parameters in laboratory research are determined by the study design and reviewed institutionally. A supplier cannot answer this question meaningfully and should not attempt to.
Q: Why does this page not list dosage ranges from published studies?
A: Because figures from published work are bound to the model, species, endpoint and formulation of the study that produced them. Presented on a product site without that context, they stop being research findings and start reading as instructions, which is neither accurate nor appropriate.
Q: Where should researchers look instead?
A: The primary literature for studies using a comparable model, read in full including methods; then institutional review of the proposed design; then pilot work to establish parameters within your own system.
Q: Is BPC-157 approved for clinical use?
A: No. BPC-157 is not approved by the FDA or any comparable regulator for any clinical indication and is not available as a prescription medicine. It is supplied strictly as a laboratory research material and is not for human or veterinary use.
Q: What documentation comes with Meta Molecule BPC-157?
A: Every batch ships with a batch-specific Certificate of Analysis from independent testing, covering HPLC purity against a 99% standard and mass spectrometry identity confirmation. COAs are published at metamolecule.com/coas/ and viewable without registration.
DISCLAIMER: This article is intended for educational and informational purposes relating to biochemical and laboratory research. It does not constitute medical advice and is not intended for diagnostic or therapeutic use. These statements have not been evaluated by the FDA. Research peptides are supplied solely for laboratory study by qualified professional researchers and are not intended for human or veterinary consumption.
